Recruiting Thiotepa-based Conditioning Regimen With De-escalated Post-graft Cyclophosphamide for Allogeneic Stem Cell Transplantation in Hematologic Malignancies NCT07565220 Conditions Acute Leukemia, Acute Lymphocytic Leukemia (ALL), Acute Myeloid Leukemia (AML), +19 more Locations UMPC Hillman Cancer Center — Pittsburgh, Pennsylvania, United States View Trial Details
Recruiting A Phase 1B/2A Trial of NADUNOLIMAB in Combination With Azacitidine (With/Without Venetoclax) in Patients With Myelodysplastic Syndrome (MDS) and Acute Myelogenous Leukemia (AML) NCT06548230 Conditions Acute Myelogenous Leukemia (AML), Bone Marrow Diseases, Hematologic Diseases, +8 more Locations MD Anderson Cancer Center — Houston, Texas, United States View Trial Details
Enrolling by Invitation Reduced Intensity Conditioning Regimens for Acute Myeloid Leukemia and Myelodysplastic Syndrome NCT05674539 Conditions Acute Myeloid Leukemia, Adult, Allogeneic Hematopoietic Stem Cell Transplantation, Bone Marrow Diseases, +9 more Locations Wuhan Union Hospital, Tongji Medical college, Huazhong University of Science and Technology — Wuhan, Hubei, China View Trial Details
Completed TPO-Mimetic Use in Children for Hematopoietic Failure NCT04478227 Conditions Anemia, Anemia, Aplastic, Aplastic Anemia, +10 more Locations University of Iowa Hospitals & Clinics — Iowa City, Iowa, United States View Trial Details
Completed Shorter Course Tacrolimus After Nonmyeloablative, Related Donor BMT With High-dose Posttransplantation Cyclophosphamide NCT01342289 Conditions Blood Protein Disorders, Bone Marrow Diseases, Cardiovascular Diseases, +22 more Locations Sidney Kimmel Comprehensive Cancer Center — Baltimore, Maryland, United States View Trial Details
